Urokinase: Difference between revisions
From Proteopedia
Jump to navigationJump to search
Michal Harel (talk | contribs) New page: {{STRUCTURE_3ig6| PDB=3ig6 | SIZE=400| SCENE= |right|CAPTION=Human urokinase A and B chains complex with inhibitor, 3ig6 }} '''Urokinase''' (UK) is a serine protease whose principa... |
Michal Harel (talk | contribs) No edit summary |
||
| (41 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
<StructureSection load='3ig6' size='350' side='right' caption='Human urokinase light chain fragment (pink) and catalytic domain (yellow) complex with inhibitor and phosphate, [[3ig6]]' scene='' > | |||
== Function == | |||
'''Urokinase''' (UK) or '''urokinase plasminogen activator''' or '''urokinase-type plasminogen activator''' is a serine protease whose principal substrate is plasminogen – the inactive zymogen of plasmin<ref>PMID:21711235</ref>. UK consists of 3 domains: ligand-binding domain and kringle and growth factor domains. Prourokinase (PUK) is the inactive zymogen of UK which becomes active by proteolytic cleavage into catalytic domain (residues 179-431) and short chain (residues 156-178). | |||
== Relevance == | |||
Increased levels of UK are associated with poor prognosis in patients with breast cancer and thus is used as prognostic markers for the disease<ref>PMID:15944776</ref>. | |||
== Structural highlights == | |||
The <scene name='46/465442/Cv/10'>inhibitor of UK binds in the active site of UK</scene> and interacts with the active Ser of the catalytic triad<ref>PMID:19703768</ref>. Water molecules are shown as red spheres. | |||
== 3D Structures of urokinase == | == 3D Structures of urokinase == | ||
[[Urokinase 3D Structures]] | |||
</StructureSection> | |||
==References== | |||
<references /> | |||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Latest revision as of 11:03, 14 March 2024
| ||||||||||||
